WO2023105481 - PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HBV
National phase entry is expected:
Publication Number
WO/2023/105481
Publication Date
15.06.2023
International Application No.
PCT/IB2022/061995
International Filing Date
09.12.2022
Title **
[English]
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HBV
[French]
COMPOSITIONS PHARMACEUTIQUES POUR LE TRAITEMENT DU VHB
Applicants **
ASSEMBLY BIOSCIENCES, INC.
Inventors
ZONG, Zhixin
WHITE, Nicole
MOHAMMED, Noorullah, Naqvi
Priority Data
63/288,188
10.12.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3023 | |
| EPO | Filing, Examination, Granting | 18697 | |
| Japan | Filing, Examination, Granting | 2460 | |
| South Korea | Filing, Examination, Granting | 2641 | |
| USA | Filing, Examination, Granting | 5560 |
Total:
32,381
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates pharmaceutical compositions comprising a solid dispersion. More specifically, the present invention relates to pharmaceutical compositions for the treatment of Hepatitis B Virus (HBV). The present invention also relates to processes for the preparation of these pharmaceutical compositions.[French]
La présente invention concerne des compositions pharmaceutiques comprenant une dispersion solide. Plus spécifiquement, la présente invention concerne des compositions pharmaceutiques pour le traitement du virus de l'hépatite B (VHB). La présente invention concerne également des procédés de préparation de ces compositions pharmaceutiques.